INDIAN PHARMA INDUSTRY – WHAT’S NEXT?
Journal: Indian Drugs (Vol.55, No. 10)Publication Date: 2018-10-29
Abstract
Dr. Shenoy completed his Bachelor's, Master's and Ph.D studies in Pharmaceutical Sciences from College of Pharmaceutical Sciences (COPS), Manipal. Prior to joining Novartis, he has worked for Lupin Limited, Mylan Laboratories Ltd., Cadila Pharmaceuticals Ltd., Novavax (USA), Northeastern University (USA), Max Planck Institute of Colloids & Interfaces (Germany) & Sun Pharma Advanced Research Centre.
Other Latest Articles
- THE PURSUIT OF NEW CHINESE TIMBER STRUCTURE ARCHITECTURE TECHNOLOGY
- THE CONTRIBUTION OF INFORMAL TRADING TO TOURISM DEVELOPMENT- THE CASE STUDY OF TSHAKUMA FRUIT MARKET, LIMPOPO, SOUTH AFRICA
- INFLUENCE OF USING DISCRETE CROSS-SECTION VARIABLES FOR ALL TYPES OF TRUSS STRUCTURAL OPTIMIZATION WITH DYNAMIC CONSTRAINTS FOR BUCKLING
- THE STRUCTURAL SOLUTIONS OF THE TIMBER ROOFS: JOINTS AND JOINING PLATES
- ANALYSIS OF ROUGHNESS PARAMETERS OF LATERAL BACK SURFACES OF MODEL HOB MILLING TOOLS DURING CYLINDRICAL GEAR CUTTING
Last modified: 2018-11-01 16:18:06